Zobrazeno 1 - 10
of 43
pro vyhledávání: '"S Ortonobes"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gemma Navarro, M. Cervantes, Oriol Gasch, Aina Gomila, M L Machado, E Prieto, E Van den Eynde, J Oristrell, J C Oliva, L Falgueras, S Calzado, S Ortonobes, A Morón, Silvia Capilla, M. Navarro
Publikováno v:
Infectious Diseases (London, England)
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Background There is an urgent need to reduce mortality of COVID-19. We examined if corticosteroids and tocilizumab reduce risk for death in patients with severe pneumonia caused by SARS-CoV-2. Methods A retrospective cohort study was performed in a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b11a77a4d581afc30774e203c528d8
https://doi.org/10.1080/23744235.2021.1884286
https://doi.org/10.1080/23744235.2021.1884286
Publikováno v:
Section 7: Post Congress additions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c9bc583ffff76810e40d4ce6149a61c
https://doi.org/10.1136/ejhpharm-2022-eahp.411
https://doi.org/10.1136/ejhpharm-2022-eahp.411
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Anaemia is an important comorbidity in heart failure (HF), and iron deficiency (ID) is the commonest contributing factor. Intravenous iron therapy improves quality of life although data in elderly patients are scarce. Aim an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29f7fd3cd8848764c7d940128bfc6332
https://doi.org/10.1136/ejhpharm-2021-eahpconf.230
https://doi.org/10.1136/ejhpharm-2021-eahpconf.230
Autor:
I Torrente Jiménez, M Gómez-Valent, E Van den Eynde Otero, N Soler-Blanco, S Ortonobes Roig, Marc Moreno-Ariño
Publikováno v:
Revista Española de Quimioterapia
Introduction. Despite the impact of SARS-CoV-2 infection in geriatrics, data on nonagenarian patients is scarce. The aim of this study is to describe the clinical features of COVID19-diagnosed nonagenarians, as well as its clinical evolution and ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24a80e73fbedc75931eed0aa6ae9ce0
https://pubmed.ncbi.nlm.nih.gov/33522213
https://pubmed.ncbi.nlm.nih.gov/33522213
Autor:
S Ortonobes Roig, A Perez Contel, G Diestre Ortin, P Miralles-Albors, A Barragán Muñoz, S Fernández-Molina, M Gómez-Valent, N Soler Blanco
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Elderly patients often manifest behavioural disorders. They commonly involve the use of psychotropic drugs that are associated with drowsiness, confusion and risk of falls, especially in this vulnerable population. The signi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7147d3bc5a0eca75d39b30e01bfdd024
https://doi.org/10.1136/ejhpharm-2020-eahpconf.240
https://doi.org/10.1136/ejhpharm-2020-eahpconf.240
Autor:
P Miralles-Albors, M Cabrera Pajaron, M Gómez-Valent, MA Villarino Marzo, R Comet Monte, L Badia Cebada, S Fernández-Molina, G Puig Comas, A Perez Contel, S Ortonobes Roig, Mdc Navarro Sáez
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Hyponatraemia is the most frequent electrolyte disorder among elderly patients (9.4%–15.0% of prevalence). It is rarely attributed to pharmacological causes despite being one of the most common drug-induced electrolyte abnormalities. Alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d18bf7f4316d232bc1b781bcc95adc8
https://doi.org/10.1136/ejhpharm-2019-eahpconf.575
https://doi.org/10.1136/ejhpharm-2019-eahpconf.575
4CPS-261 Grade of chronicity in nonagenarians: can we compare number and type of drug interventions?
Autor:
MA Villarino Marzo, S Ortonobes Roig, M Gómez-Valent, G Puig Comas, P Miralles Albors, G Molas, R Comet Monte, A Perez Contel
Publikováno v:
Eur J Hosp Pharm
Background Impaired functionality, cognitive decline, comorbidity and polypharmacy in nonagenarians increase mortality risks associated with age. Polypharmacy (>4 chronic drugs) in elderly people is related to an increase in drug-related problems (DR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c27e8d4e08927042e67701bbfa0f15c2
https://doi.org/10.1136/ejhpharm-2018-eahpconf.351
https://doi.org/10.1136/ejhpharm-2018-eahpconf.351
Publikováno v:
Patient safety and risk management.
Background Identifying the risk factors in patients that are more susceptible to drug related problems (DRPs) promotes closer pharmacotherapy monitoring that prevents morbidity–mortality in these patients. Purpose To develop a predictive model of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::210d27179251e567aba869fdad18a9e6
https://doi.org/10.1136/ejhpharm-2017-000640.560
https://doi.org/10.1136/ejhpharm-2017-000640.560
Autor:
M Gómez-Valent, M Cirera i Perich, L Borràs Trias, S Ortonobes Roig, B Mañé Velilla, MQ Gorgas Torner
Publikováno v:
Patient safety and risk management.
Background Chronic treatment revisions optimise drug treatment and prevent potential drug related problems. Therefore, we started a new healthcare model based on multidisciplinary team work, integrated and focused on the patient. This programme is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6a5c5db801f90a3a32cc5724930745b
https://doi.org/10.1136/ejhpharm-2017-000640.561
https://doi.org/10.1136/ejhpharm-2017-000640.561